Max Healthcare Institute Ltd
NSE:MAXHEALTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (64.9), the stock would be worth ₹1 151.18 (16% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 56 | ₹993.05 |
0%
|
| 3-Year Average | 64.9 | ₹1 151.18 |
+16%
|
| 5-Year Average | 62 | ₹1 099.4 |
+11%
|
| Industry Average | 36.2 | ₹641.35 |
-35%
|
| Country Average | 23 | ₹406.96 |
-59%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
965.5B INR | 56 | 67.8 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
97.1B USD | 7.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 28.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 9.7 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 14 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 3.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 157.2 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.4B USD | 4.5 | 11.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 17.2 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 31.6 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 18.9 | 31.1 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 14 |
| Median | 23 |
| 70th Percentile | 39.7 |
| Max | 28 676 |
Other Multiples
Max Healthcare Institute Ltd
Glance View
Max Healthcare Institute Ltd., a prominent player in the Indian healthcare landscape, has woven its narrative by consistently providing top-tier healthcare services across the country. Founded as a partnership between Max India Limited and the renowned healthcare provider, Life Healthcare of South Africa, Max Healthcare has expanded its reach with a network of multispecialty hospitals, catering to various medical needs. The company prides itself on delivering holistic and patient-centric care, offering a wide array of services ranging from complex surgeries and emergency care to preventive health services and diagnostics. This comprehensive approach ensures that Max Healthcare not only addresses immediate health needs but also emphasizes long-term wellness, thus fortifying its reputation as a reliable healthcare provider. Financially, Max Healthcare Institute thrives on its diversified revenue streams. These streams are primarily built on inpatient and outpatient services, where it capitalizes on its state-of-the-art infrastructure and advanced medical technology to attract patients. Additionally, Max Healthcare leverages its brand to engage in partnerships, collaborations, and clinical research, thereby generating ancillary revenue. The company also benefits from health awareness programs and corporate health tie-ups, which feed a steady flow of patients into its facilities. Through these strategic efforts, Max Healthcare has established a robust framework that supports its profitability while continuing to expand its footprint in the increasingly competitive healthcare industry in India.